Filing Details
- Accession Number:
- 0000950170-24-061293
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-16 19:36:33
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-16 19:36:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658551 | Amylyx Pharmaceuticals Inc. | AMLX | Pharmaceutical Preparations (2834) | 464600503 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1913765 | Gina Mazzariello | C/O Amylyx Pharmaceuticals, Inc. 43 Thorndike Street Cambridge MA 02141 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-15 | 10,455 | $1.88 | 151,477 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2023.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.82 to $1.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
